GOTHENBURG,Sweden,Jan. 22,2025 -- SKF's Nomination Committee proposes Mats Rahmström as a new board member in AB SKF.
Mats Rahmström was the President and CEO,as well as a member of the Board of Directors of Atlas Copco Group up until April 2024 and has held several senior positions within Atlas Copco. He has a broad international industrial background and is the Chair of the Board of Directors in Piab Group AB and a board member in Investor AB,ABB Ltd,Wärtsilä Oyj,R12 Distribution AB and Qvantum AB.
The Nomination Committee,furthermore,in addition to the proposed new election of Mats Rahmström,proposes re-election of the board members Hans Stråberg,Hock Goh,Geert Follens,Håkan Buskhe,Susanna Schneeberger,Rickard Gustafson,Beth Ferreira,Therese Friberg,Richard Nilsson and Niko Pakalén.
Hans Stråberg is proposed to be the Chair of the Board of Directors.
The Nomination Committee's additional proposals will be published in conjunction with the notice of the Annual General Meeting 2025.
The Nomination Committee for the Annual General Meeting 2025 consists of Marcus Wallenberg,FAM,Philip Ahlgren,Cevian Capital,Anders Algotsson,AFA Försäkring,and Anders Jonsson,Skandia,together with the Chair of the Board of Directors Hans Stråberg.
Aktiebolaget SKF
(publ)
For further information,please contact:
PRESS: Carl Bjernstam,Head of Media Relations
tel: 46 31-337 2517;mobile: 46 722-201 893;e-mail: [email protected]
INVESTOR RELATIONS: Sophie Arnius,Head of Investor Relations
tel: 46 31-337 8072; mobile: 46 705-908 072; e-mail: [email protected]
This information was brought to you by Cision http://news.cision.com.
https://news.cision.com/skf/r/nomination-committee-s-proposal-for-board-of-directors-of-ab-skf,c4094554
The following files are available for download:
https://mb.cision.com/Main/637/4094554/3217469.pdf
20250122 Nomination Committees proposal for Board of Directors of AB SKF
https://news.cision.com/skf/i/dji-0735-fix,c3370261
DJI 0735 fix
SHANGHAI,March 17,2025-- Singapore Treasure Carbon TechPte. Ltd. (SGTC) and CHCC Capital (Singapore) Pte. Ltd. have jointly launched a fund that will invest in international carbon credit assets compl
HANGZHOU,China,March 17,2025--Chance Pharmaceuticals ("Chance Pharma"),a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapies,to
Six new models announced for AI-enhanced gaming,streaming,and creation with 8K visuals and optimized thermal design with triple FrostBlade 4.0 cooling fans
SHANGHAI,March 3,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors